What to know about the new bird flu virus

May 14, 2013 by Angela Herring
The info­graphic demon­strates the cur­rent state of the impact of H7N9 on global health. Credit: Nicole Samay

Earlier this month, the U.S. government declared that the emerging H7N9 bird flu "poses a significant potential for a public health emergency." The virus, a relative of other bird flus we've seen previously like H1N1 and H5N1, originated in China and results in a severe respiratory infection and, in some cases, death. While the virus is not, at this time, transmissible between humans, researchers believe that just a few genetic mutations could change that. Network scientist Alessandro Vespignani, the Sternberg Family Distinguished University Professor of physics, computer science, and health sciences, is mapping the disease's progression in his lab. We asked him to discuss the pandemic potential of the virus and explain how this strain differs from those in the past.

How is H7N9 different from other bird flu viruses we've seen in the past?

The H7N9 is a novel reassortant , which very likely originated in birds. However, the transmission of H7 viruses to mammals has seldom been reported, and with N9 subtype viruses had not been documented anywhere in the world before this outbreak. In addition, most of the observed infections are associated with severe symptoms and a high mortality rate. As of today there have been 130 human cases suggesting that the virus appears to be more infectious to people than most of the other avian we know. For instance, in China the feared is at the origin of less than 50 cases in one decade. Indeed, it appears that the H7N9 virus shows several mutations that make it more adapted to mammals, and thus humans.

What would it take for H7N9 to become a pandemic threat and how concerned are officials about it reaching that point in the near future?

So far the virus does not have sustained human-to-human transmission. This means that although there have been small family clusters likely triggered by the prolonged exposure to the infectious individual, the virus cannot spread easily in the general population. At the moment it is an infection that people catch from animals, however the circulation among humans may favor further genetic adaptation increasing the transmission potential of the virus. Generally these changes are associated with mild and asymptomatic cases that signal an increased adaptation of the virus to the human host. For this reason, the identification of one asymptomatic case and a few relatively mild cases have raised concerns about the virus. There is an appreciable risk that a pandemic could start if this virus were to change to spread easily between people. The Centers for Disease Control and Prevention, as well as all national and international agencies, are seriously preparing for that possibility.

Based on your modeling projections, what impact do you think the H7N9 strain will have on the global population?

At the moment, the lack of human-to- makes the spreading pattern of the current outbreak not compatible with any widespread epidemic scenario. It is however possible that isolated cases will be observed in other countries because of travelers from China. If the virus acquires the capability of sustained transmission, the situation would be completely different. In that case it is very likely that the epidemic could escalate to pandemic dimensions in two to three months, as we observed for the H1N1 in 2009. Detailed projections, however, would need specific information on the adapted virus, and the initial pattern of spreading. For this reason it is extremely important to increase and enhance surveillance capabilities not just in China but worldwide. We are in the position to use new digital technologies to monitor the progression of widespread epidemics by tapping into social networks, mobile devices, and web platforms. The next pandemic will be the first one that we will fight not just on the medical frontline but also by using "information intelligence," which will allow us to predict the moves of the biological enemy.

Explore further: H7N9 bird flu spreads to southern China

Related Stories

H7N9 bird flu spreads to southern China

April 26, 2013
China's deadly outbreak of H7N9 bird flu has spread to a province in the country's south, the government said Friday, marking the second announcement in two days of a case in a new location.

China reports 24th death from new bird flu

April 29, 2013
The deadly H7N9 bird flu strain claimed a new victim on Monday when a hospital patient died in China, state media reported, bringing the death toll from the recently identified virus to 24.

No 'sustained' human-to-human transmission of bird flu, WHO says

April 22, 2013
A top WHO influenza expert said Monday there was still no evidence H7N9 bird flu was spreading in a "sustained" way between people in China, despite the possibility some family members may have infected one another.

New flu virus found in China, travelers urged to follow guidelines from experts

May 8, 2013
In late March 2013, China notified the World Health Organization (WHO), that it had identified a new flu virus in patients who had become ill. The new virus, avian influenza A (H7N9) virus, had not been found in humans until ...

H7N9 flu 'one of most lethal' says WHO as spreads to Taiwan (Update)

April 24, 2013
International experts probing China's deadly H7N9 bird flu virus said Wednesday it was "one of the most lethal influenza viruses" seen so far as Taiwan reported the first case outside the mainland.

China reports 27th death from H7N9 bird flu (Update)

May 2, 2013
The death toll from the H7N9 bird flu virus has risen to 27, state media said Thursday after a man died in central China's Hunan Province.

Recommended for you

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.